Skip to main content


Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus

In current management of type 2 diabetes (T2DM), cardiovascular and renal prevention have become important targets to be achieved. In this context, a joint panel of four endocrinology societies from Brazil and Portugal was established to develop an evidence-based guideline for treatment of hyperglycemia in T2DM.


  1. Authors: Marcello Casaccia Bertoluci, João Eduardo Nunes Salles, José Silva-Nunes, Hermelinda Cordeiro Pedrosa, Rodrigo Oliveira Moreira, Rui Manuel Calado da Silva Duarte, Davide Mauricio da Costa Carvalho, Fábio Rogério Trujilho, João Filipe Cancela dos Santos Raposo, Erika Bezerra Parente, Fernando Valente, Fábio Ferreira de Moura, Alexandre Hohl, Miguel Melo, Francisco Garcia Pestana Araujo, Rosa Maria Monteiro Castro de Araújo Principe…

    Content type: Review

Announcement: Covid-19

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Our systems will continue to remind authors, reviewers and editors of the original timelines but we intend to be highly flexible at this time.

Aims and scope

Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome.

By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.

The journal aims to help health care providers improve the management of people afflicted by these syndromes by increasing knowledge and stimulating research in the field.

About the editor

Dr. Sérgio VencioEditor-in-Chief Dr. Sérgio Vencio is active in the field of Endocrinology. He is a professor in the Post Graduate Program at the Federal University of Goiás, a Principal Investigator at the Pharmaceutical Institute of Science and has participated as a PI in more than 70 clinical studies. Since 2008, he has been the Editor of the Brazilian Diabetes Society Guidelines. He is the Coordinator of Neuroendocrinology at the Hospital Araujo Jorge, the Medical Director at Diagnostics of America - Atalaia, and a member of the Diabetes Board for the Brazilian Society of Endocrinology.


The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics